Rui Cui

730 total citations
40 papers, 425 citations indexed

About

Rui Cui is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Rui Cui has authored 40 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Rui Cui's work include CAR-T cell therapy research (14 papers), Lymphoma Diagnosis and Treatment (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Rui Cui is often cited by papers focused on CAR-T cell therapy research (14 papers), Lymphoma Diagnosis and Treatment (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Rui Cui collaborates with scholars based in China, United States and Hong Kong. Rui Cui's co-authors include Qi Deng, Meijing Liu, Cuicui Lyu, Wenyi Lu, Ting Yuan, Jia Wang, Qing Li, Jijun Yuan, Hongyan Ni and Jingyi Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Cell.

In The Last Decade

Rui Cui

37 papers receiving 416 citations

Peers

Rui Cui

ONCOL

HEMAT

GENET

IMMUN

Hoyoung Maeng United States

Maria Antonella Laginestra Italy

Susann Winter Germany

Stefan O. Peters Germany

Rachel L. Morgan United States

Elham Roshandel Iran

Ashley Ringrose Canada

Zhongxing Jiang China

L. Dousset France

Wolfgang Peter Germany

Hoyoung Maeng United States

Rui Cui

154 ×0.9

ONCOL

168 ×1.2

HEMAT

86 ×0.7

GENET

289 ×2.4

103 ×1.4

IMMUN

Citations per year, relative to Rui Cui Rui Cui (= 1×) peers Hoyoung Maeng

Countries citing papers authored by Rui Cui

Since Specialization

Citations

This map shows the geographic impact of Rui Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Cui more than expected).

Fields of papers citing papers by Rui Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Cui. The network helps show where Rui Cui may publish in the future.

Co-authorship network of co-authors of Rui Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Cui. A scholar is included among the top collaborators of Rui Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Cui. Rui Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mu, Juan, Rui Cui, Xin Li, et al.. (2024). Efficacy and side effects of anti‐CD19 CAR T‐cell therapy in patients with relapsed/refractory gastrointestinal lymphoma. Cancer Medicine. 13(4). e7064–e7064. 1 indexed citations

Li, Xin, Rui Cui, Jia Wang, et al.. (2023). Efficacy and Safety of Ino Combined with Reduce Dose R-GDP Regimen in Patients with Relapsed/Refractory B-Cell NHL in China. Blood. 142(Supplement 1). 6880–6880.

Fan, Xuemei, Rui Cui, Juan Mu, et al.. (2023). Efficacy and safety-related factors of BTK inhibitors as a bridge to CAR-T therapy in R/R FL. Annals of Hematology. 102(7). 1789–1799. 1 indexed citations

Cui, Rui, et al.. (2022). Research Progress on Trajectory Planning of Fracture Reduction and Deformity Correction Robot. Journal of Mechanical Engineering. 58(13). 1–1. 1 indexed citations

Sun, Zhenhui, et al.. (2021). A machine learning‐based method for automatic diagnosis of ankle fracture using X‐ray images. International Journal of Imaging Systems and Technology. 32(3). 831–842. 7 indexed citations

Cui, Rui, et al.. (2021). Hill‐based musculoskeletal model for a fracture reduction robot. International Journal of Medical Robotics and Computer Assisted Surgery. 17(3). 1–14. 5 indexed citations

Feng, Yingna, et al.. (2021). Repression of transcription factor AtWRKY47 confers tolerance to boron toxicity in Arabidopsis thaliana. Ecotoxicology and Environmental Safety. 220. 112406–112406. 15 indexed citations

Mu, Juan, et al.. (2021). [In vitro studies on the transfer of CAR into leukemia cells due to their residue in the autologous CAR-T cell preparation system for acute B-cell acute lymphoblastic leukemia].. PubMed Central. 42(2). 140–145. 1 indexed citations

Lyu, Cuicui, et al.. (2021). Intensive Debulking Chemotherapy Improves the Short-Term and Long-Term Efficacy of Anti-CD19-CAR-T in Refractory/Relapsed DLBCL With High Tumor Bulk. Frontiers in Oncology. 11. 706087–706087. 11 indexed citations

10.

Liu, Meijing, Ting Yuan, Huan Zhang, et al.. (2021). Efficacy of Humanized Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With and Without Extramedullary Disease. Frontiers in Immunology. 12. 720571–720571. 36 indexed citations

11.

Liu, Meijing, Cuicui Lyu, Wenyi Lu, et al.. (2020). Acute Graft-Versus-Host Disease After Humanized Anti-CD19-CAR T Therapy in Relapsed B-ALL Patients After Allogeneic Hematopoietic Stem Cell Transplant. Frontiers in Oncology. 10. 573822–573822. 39 indexed citations

12.

Wang, Xiaozhen, et al.. (2020). Comparison of the accuracy of intraocular lens power calculation formulas for eyes after corneal refractive surgery. Annals of Translational Medicine. 8(14). 871–871. 5 indexed citations

13.

Cui, Rui, Cuicui Lyu, Qing Li, et al.. (2020). Humanized anti‐CD19 chimeric antigen receptor‐T cell therapy is safe and effective in lymphoma and leukemia patients with chronic and resolved hepatitis B virus infection. Hematological Oncology. 39(1). 75–86. 19 indexed citations

14.

Jin, Xin, Xiaoyuan He, Xiaoli Cao, et al.. (2018). Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice. Haematologica. 103(10). 1627–1634. 48 indexed citations

15.

Yi, Shuhua, Zengjun Li, Dehui Zou, et al.. (2016). Intratumoral genetic heterogeneity and number of cytogenetic aberrations provide additional prognostic significance in chronic lymphocytic leukemia. Genetics in Medicine. 19(2). 182–191. 13 indexed citations

16.

Yi, Shuhua, Rui Cui, Zengjun Li, et al.. (2014). Distinct characteristics and new prognostic scoring system for Chinese patients with Waldenström macroglobulinemia. Chinese Medical Journal. 127(12). 2327–2331. 4 indexed citations

17.

Cui, Rui, Robert Peter Gale, Zefeng Xu, et al.. (2014). Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions. Leukemia Research. 38(5). 545–550. 40 indexed citations

18.

Cui, Rui, Xianglin Duan, Gregory J. Anderson, et al.. (2009). Age-dependent expression of hephaestin in the brain of ceruloplasmin-deficient mice. Journal of Trace Elements in Medicine and Biology. 23(4). 290–299. 7 indexed citations

19.

Cui, Rui, Yan‐Zhong Chang, Wenshuang Wu, et al.. (2008). Hepcidin, an antimicrobial peptide is downregulated in ceruloplasmin-deficient mice. Peptides. 30(2). 262–266. 18 indexed citations

20.

Yu, Peng, Yan‐Zhong Chang, Shumin Wang, et al.. (2008). Effects of Intracerebroventricular Injection of Iron Dextran on the Iron Concentration and Divalent Metal Transporter 1 Expression in the Caudate Putamen and Substantia Nigra of Rats. The Anatomical Record. 292(2). 225–233. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact